A run of legislative action across the United States and Australia is broadening medical cannabis access, while a new peer-reviewed study adds clinical weight to one of the plant’s therapeutic applications. Iowa and Pennsylvania have both passed bills expanding patient rights; New South Wales has moved to align drug-driving rules with medical prescribing practice. An investigation published today in Connecticut, meanwhile, shows how industry lobbying can strip transparency provisions from cannabis legislation before it reaches the statute book.
Connecticut’s cannabis sector used its legislative influence to remove a mandatory disclosure requirement from Public Act 26-8 before Governor Ned Lamont signed the bill into law on 22 May, CT Mirror reported on Thursday. Earlier drafts would have obliged producers to label cannabis flower that had undergone ionising radiation treatment to eliminate microbial contamination, following the same standard the US Food and Drug Administration applies to irradiated food. The final text replaced that requirement with generic dispensary signage, a change critics say prioritises producer convenience over the consumer transparency that a mature regulated market demands.
Iowa Governor Kim Reynolds signed HF 990 into law, raising the state’s medical cannabis dispensary limit from five to ten locations. The bill passed with near-unanimous bipartisan support, 88 votes to 5 in the House and 42 to 5 in the Senate, responding to longstanding concerns about patient access in rural areas. Marijuana Moment reported that the law also extends eligibility to out-of-state residents holding a valid certification from an Iowa healthcare provider, a provision that could draw patients from neighbouring states into Iowa’s regulated framework.
Pennsylvania’s House of Representatives passed HB 2254 by 174 votes to 27, allowing terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. Under the legislation, covered facilities would have 180 days to develop safety guidelines, and cannabis use would be permitted only where it does not interfere with patient treatment or affect others in the facility, according to Marijuana Moment. The bill now moves to the state Senate. If enacted, Pennsylvania would join a growing number of states that have carved out specific access provisions for end-of-life patients, a category of use that has attracted consistent cross-party support.
New South Wales has tabled legislation that would make it the first Australian state to allow medical cannabis patients with a valid prescription to drive while carrying measurable THC in their system. The Marijuana Herald reported that the scheme, backed by Premier Chris Minns, would apply only to full, unrestricted licence holders who complete an approved safety programme and remain below a designated THC threshold. Minns argued that zero-tolerance rules are inconsistent with how the law treats patients using other prescription drugs. The proposal reflects a challenge regulators in several jurisdictions face: how to align drug-driving enforcement with an established medical prescribing framework without compromising road safety.
A meta-analysis of eight clinical studies covering 306 adults has found that cannabis-based medicines significantly reduced tics and the urge to tic in patients with Tourette syndrome, The Marijuana Herald reported. Researchers attributed the effect to interactions with the endocannabinoid system and suggested these compounds may offer better tolerability than antipsychotic drugs currently used for the condition. The authors stopped short of endorsing routine clinical use, noting that the evidence base consists of studies too small and heterogeneous to confirm optimal dosing. The findings contribute to the growing clinical literature that participants in the upcoming DEA rescheduling hearing, set to begin on 29 June, will need to weigh when evaluating the case for broadened medical access.
Watch this week for the Rhode Island Senate and House floor votes on the state’s cannabis licensing bill, scheduled after it advanced from committee with provisions to restart the retail licensing process and refund previous applicants. The result will signal whether the state can agree on a framework that preserves social equity commitments while opening new licences.
The post Cannabis News Today — Thursday 4 June 2026: Legislators Widen Medical Cannabis Access as New Research Backs Therapeutic Potential appeared first on Business of Cannabis.
Continue reading...
Connecticut Cannabis Industry Sidelines Labelling Rules in Signed Legislation
Connecticut’s cannabis sector used its legislative influence to remove a mandatory disclosure requirement from Public Act 26-8 before Governor Ned Lamont signed the bill into law on 22 May, CT Mirror reported on Thursday. Earlier drafts would have obliged producers to label cannabis flower that had undergone ionising radiation treatment to eliminate microbial contamination, following the same standard the US Food and Drug Administration applies to irradiated food. The final text replaced that requirement with generic dispensary signage, a change critics say prioritises producer convenience over the consumer transparency that a mature regulated market demands.
Iowa Doubles Dispensary Cap to Improve Rural Patient Access
Iowa Governor Kim Reynolds signed HF 990 into law, raising the state’s medical cannabis dispensary limit from five to ten locations. The bill passed with near-unanimous bipartisan support, 88 votes to 5 in the House and 42 to 5 in the Senate, responding to longstanding concerns about patient access in rural areas. Marijuana Moment reported that the law also extends eligibility to out-of-state residents holding a valid certification from an Iowa healthcare provider, a provision that could draw patients from neighbouring states into Iowa’s regulated framework.
Pennsylvania House Passes Hospital Cannabis Access for Terminally Ill Patients
Pennsylvania’s House of Representatives passed HB 2254 by 174 votes to 27, allowing terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. Under the legislation, covered facilities would have 180 days to develop safety guidelines, and cannabis use would be permitted only where it does not interfere with patient treatment or affect others in the facility, according to Marijuana Moment. The bill now moves to the state Senate. If enacted, Pennsylvania would join a growing number of states that have carved out specific access provisions for end-of-life patients, a category of use that has attracted consistent cross-party support.
New South Wales Proposes First Australian Exemption for Medical Cannabis Drivers
New South Wales has tabled legislation that would make it the first Australian state to allow medical cannabis patients with a valid prescription to drive while carrying measurable THC in their system. The Marijuana Herald reported that the scheme, backed by Premier Chris Minns, would apply only to full, unrestricted licence holders who complete an approved safety programme and remain below a designated THC threshold. Minns argued that zero-tolerance rules are inconsistent with how the law treats patients using other prescription drugs. The proposal reflects a challenge regulators in several jurisdictions face: how to align drug-driving enforcement with an established medical prescribing framework without compromising road safety.
Meta-Analysis Links Cannabis Medicines to Reduced Tics in Tourette Syndrome
A meta-analysis of eight clinical studies covering 306 adults has found that cannabis-based medicines significantly reduced tics and the urge to tic in patients with Tourette syndrome, The Marijuana Herald reported. Researchers attributed the effect to interactions with the endocannabinoid system and suggested these compounds may offer better tolerability than antipsychotic drugs currently used for the condition. The authors stopped short of endorsing routine clinical use, noting that the evidence base consists of studies too small and heterogeneous to confirm optimal dosing. The findings contribute to the growing clinical literature that participants in the upcoming DEA rescheduling hearing, set to begin on 29 June, will need to weigh when evaluating the case for broadened medical access.
Watch this week for the Rhode Island Senate and House floor votes on the state’s cannabis licensing bill, scheduled after it advanced from committee with provisions to restart the retail licensing process and refund previous applicants. The result will signal whether the state can agree on a framework that preserves social equity commitments while opening new licences.
The post Cannabis News Today — Thursday 4 June 2026: Legislators Widen Medical Cannabis Access as New Research Backs Therapeutic Potential appeared first on Business of Cannabis.
Continue reading...
